The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 18, 2023
Filed:
Mar. 14, 2018
Applicants:
Biontech Cell & Gene Therapies Gmbh, Mainz, DE;
Tron—translationale Onkologie an Der Universitätsmedizin Der Johannes Gutenberg-universitat Mainz Gemeinnutzige Gmbh, Mainz, DE;
Inventors:
Ralf Holger Voss, Ingelheim, DE;
Ugur Sahin, Mainz, DE;
Petra Oehm, Mainz, DE;
Matthias Birtel, Mainz, DE;
Janina Caspar, Waldalgesheim, DE;
Assignees:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); C07K 19/00 (2006.01); C12N 5/0783 (2010.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01); C12N 15/90 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0636 (2013.01); C07K 14/7051 (2013.01); C07K 14/70521 (2013.01); C07K 16/28 (2013.01); C12N 15/90 (2013.01); A61K 38/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/70 (2013.01);
Abstract
The present invention generally embraces the treatment of diseases by targeting cells expressing an antigen on the cell surface. In particular the invention relates to recombinant antigen receptors and uses thereof. T cells engineered to express such antigen receptors are useful in the treatment of diseases characterized by expression of one or more antigens bound by the antigen receptors.